Literature DB >> 9195149

Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia.

P Zwirner1, D Dressler, E Kruse.   

Abstract

We describe clinical experiences in the management of three patients with laryngopharyngeal dystonia causing severe breathing problems. In contrast to spasmodic dysphonia, which presents with action-induced involuntary spasm of laryngeal muscles during speaking, all three patients showed laryngopharyngeal spasms primarily during respiration. In analogy to spasmodic dysphonia we propose the term spasmodic laryngeal dyspnea for this rare condition. Localized unilateral botulinum toxin injected into the thyroarytenoid muscle and/or ventricular folds reduced the quantity and quality of spasms and led to a pronounced improvement of breathing problems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195149     DOI: 10.1007/BF00874096

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  10 in total

1.  Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.

Authors:  G A Grillone; A Blitzer; M F Brin; D J Annino; M H Saint-Hilaire
Journal:  Laryngoscope       Date:  1994-01       Impact factor: 3.325

2.  Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases.

Authors:  A Blitzer; M F Brin; S Fahn; R E Lovelace
Journal:  Laryngoscope       Date:  1988-06       Impact factor: 3.325

3.  [Dystonia as the cause of pharyngolaryngeal motility disorders].

Authors:  P Zwirner; D Dressler
Journal:  HNO       Date:  1995-08       Impact factor: 1.284

4.  Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.

Authors:  A Fève; B Angelard; G Fénelon; M Logak; A Guillard; J Lacau Saint-Guily
Journal:  Mov Disord       Date:  1993-04       Impact factor: 10.338

5.  Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).

Authors:  M F Lew; M Shindo; C B Moskowitz; K C Wilhelmsen; S Fahn; C H Waters
Journal:  Mov Disord       Date:  1994-05       Impact factor: 10.338

6.  Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.

Authors:  R H Miller; G E Woodson; J Jankovic
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-06

7.  [Indications for botulinum toxin in laryngectomy].

Authors:  P Klap; M H Marion; A Perrin; E Fresnel-Elbaz; M Cohen
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  1993

8.  Stridor and focal laryngeal dystonia.

Authors:  M H Marion; P Klap; A Perrin; M Cohen
Journal:  Lancet       Date:  1992-02-22       Impact factor: 79.321

9.  Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.

Authors:  M F Brin; S Fahn; C Moskowitz; A Friedman; H M Shale; P E Greene; A Blitzer; T List; D Lange; R E Lovelace
Journal:  Mov Disord       Date:  1987       Impact factor: 10.338

10.  Laryngeal dystonia: a series with botulinum toxin therapy.

Authors:  A Blitzer; M F Brin
Journal:  Ann Otol Rhinol Laryngol       Date:  1991-02       Impact factor: 1.547

  10 in total
  6 in total

1.  [The application of botulinum toxin in oromandibular, pharyngeal and laryngeal dystonia].

Authors:  A Olthoff; R Laskawi
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  Sudden death in Lesch-Nyhan disease.

Authors:  Vladimir Kostadinov Neychev; H A Jinnah
Journal:  Dev Med Child Neurol       Date:  2006-11       Impact factor: 5.449

3.  Idiopathic laryngeal spasm: management and long-term outcome.

Authors:  Darren Pinder; Stephen E McDonald; Mark Medcalf; Michael W Bridger
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-11       Impact factor: 2.503

4.  Botulinum toxin injection in laryngeal dyspnea.

Authors:  Virginie Woisard; Xuelai Liu; Marie Christine Arné Bes; Marion Simonetta-Moreau
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-06       Impact factor: 2.503

Review 5.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 6.  Botulinum toxin therapy of dystonia.

Authors:  Dirk Dressler; Fereshte Adib Saberi; Raymond L Rosales
Journal:  J Neural Transm (Vienna)       Date:  2020-10-30       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.